Lilly’s Zyprexa Gets MedGuide, Labeling Update And New Indication
This article was originally published in The Pink Sheet Daily
Executive Summary
Antipsychotic clears FDA for treatment-resistant depression in combination with fluoxetine, as does combo pill Symbyax.